AKT1 and non-small cell lung carcinoma: Considering this, Park et al. [9] found that PTEN targets RAC-alpha serine/threonine-protein kinase (AKT) to generate p21 expression, which in turn causes halting cell cycle progression at the G2/M-phase in NSCLC.